---
figid: PMC4022699__bcbcr-8-2014-081f1
figlink: /pmc/articles/PMC4022699/figure/f1-bcbcr-8-2014-081/
number: F1
caption: 'The complementary signaling cascade pathway inhibition of pertuzumab given
  in conjunction with trastuzumab. HER2 and HER3 are transmembrane proteins with associated
  tyrosine kinases. They each have multiple binding sites, which are denoted, only
  slightly disparate with regard to sub-units #2 and #4. Homodimerization and heterodimerization
  both result in tyrosine kinase activation with the subsequent signaling cascade.
  Trastuzumab binds to domain IV of HER2 that designates its major difference from
  Pertuzumab, which binds to domain II of HER3.'
pmcid: PMC4022699
papertitle: 'Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment
  of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free
  Survival.'
reftext: Joseph J Maly, et al. Breast Cancer (Auckl). 2014;8:81-88.
pmc_ranked_result_index: '30349'
pathway_score: 0.8742971
filename: bcbcr-8-2014-081f1.jpg
figtitle: Complementary signaling cascade pathway inhibition of pertuzumab given in
  conjunction with trastuzumab
year: '2014'
organisms:
- Homo sapiens
ndex: f855e174-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4022699__bcbcr-8-2014-081f1.html
  '@type': Dataset
  description: 'The complementary signaling cascade pathway inhibition of pertuzumab
    given in conjunction with trastuzumab. HER2 and HER3 are transmembrane proteins
    with associated tyrosine kinases. They each have multiple binding sites, which
    are denoted, only slightly disparate with regard to sub-units #2 and #4. Homodimerization
    and heterodimerization both result in tyrosine kinase activation with the subsequent
    signaling cascade. Trastuzumab binds to domain IV of HER2 that designates its
    major difference from Pertuzumab, which binds to domain II of HER3.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - MTOR
  - MAP2K2
  - MAPK9
  - MAPK10
  - MAP2K1
  - MAPK12
  - KRAS
  - PSMA6
  - HRAS
  - MAPK14
  - MAPK8
  - ERBB2
  - MAPK13
  - MAPK11
  - MAPK3
  - MAPK1
  - ERBB3
  - AKT1
  - AKT3
  - TRA
  - NRAS
  - Tyrosine
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: p27k
  symbol: p27K
  source: hgnc_alias_symbol
  hgnc_symbol: PSMA6
  entrez: '5687'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Her2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Her3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Tras
  symbol: TRA
  source: hgnc_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4022699__F1
redirect_from: /figures/PMC4022699__F1
figtype: Figure
---
